| Bioactivity | Adalimumab beta (ABP-501) is an anti-TNF-α monoclonal antibody. Adalimumab beta can be used in research of rheumatoid arthritis (RA)[1]. |
| Target | TNF-α |
| Name | Adalimumab beta |
| CAS | 1446410-95-2 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Pelechas E, et, al. ABP 501 for the treatment of rheumatoid arthritis. Expert Opin Biol Ther. 2018 Mar;18(3):317-322. |